convEyXO
ConvEyXO develops RNA-enhanced exosomes designed to treat degenerative diseases by reducing inflammation and restoring cellular balance.
ConvEyXO develops miRNA-enhanced exosome therapeutics to address degenerative diseases at their biological roots and extend healthspan. The company uses stem cell-derived exosomes as cell-free therapies to target inflammation and cellular aging across multiple disease pathways.
Key People
Frédéric Tonglet - CEO